Studies have shown that hypertension and dyslipidemia promote the formation of atherosclerotic plaques through various complex pathophysiological mechanisms, including oxidative stress, pro-inflammatory responses, activation of the renin-angiotensin-aldosterone system (RAAS), and endothelial dysfunction, thereby increasing the risk of stroke (49–51). The gene discussed is REN; the disease is endothelial dysfunction.